Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chor-Sang Chim

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
American Journal of Hematology|March 21, 2013
Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donorAnskar Y H Leung, Eric Tse, Yu-Yan Hwang, et al.
Journal of Hematology & Oncology|February 15, 2013
Epigenetic inactivation of the MIR129-2 in hematological malignanciesKwan-Yeung Wong, Rita Lok-Hay Yim, Yok-Lam Kwong, et al.
Clinical Transplantation|February 14, 2012
Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatmentThomas S Y Chan, Yu-Yan Hwang, Harinder Gill, et al.
Plos One|May 6, 2011
Epigenetic inactivation of the miR-124-1 in haematological malignanciesKwan Yeung Wong, Chi Chiu So, Florence Loong, et al.
Blood|March 5, 2005
Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapyChee-Kin Hui, Scott Bowden, Kathy Jackson, et al.
Oncotarget|September 12, 2014
Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomasRita Lh Yim, Kwan Yeung Wong, Yok Lam Kwong, et al.
Leukemia & Lymphoma|February 3, 2018
Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshopDaryl Tan, Jae Hoon Lee, Wenming Chen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Effectiveness of prophylactic Anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donorsChee-kin Hui, Albert Lie, Wing-yan Au, et al.
Annals of Hematology|August 17, 2013
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patientsThomas S Y Chan, Harinder Gill, Yu-Yan Hwang, et al.
Journal of Hematology & Oncology|September 5, 2015
Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 studyNeeraj Gupta, Yeow Tee Goh, Chang-Ki Min, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
American Journal of Hematology|March 21, 2013
Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donorAnskar Y H Leung, Eric Tse, Yu-Yan Hwang, et al.
Journal of Hematology & Oncology|February 15, 2013
Epigenetic inactivation of the MIR129-2 in hematological malignanciesKwan-Yeung Wong, Rita Lok-Hay Yim, Yok-Lam Kwong, et al.
Clinical Transplantation|February 14, 2012
Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatmentThomas S Y Chan, Yu-Yan Hwang, Harinder Gill, et al.
Plos One|May 6, 2011
Epigenetic inactivation of the miR-124-1 in haematological malignanciesKwan Yeung Wong, Chi Chiu So, Florence Loong, et al.
Blood|March 5, 2005
Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapyChee-Kin Hui, Scott Bowden, Kathy Jackson, et al.
Oncotarget|September 12, 2014
Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomasRita Lh Yim, Kwan Yeung Wong, Yok Lam Kwong, et al.
Leukemia & Lymphoma|February 3, 2018
Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshopDaryl Tan, Jae Hoon Lee, Wenming Chen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Effectiveness of prophylactic Anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donorsChee-kin Hui, Albert Lie, Wing-yan Au, et al.
Annals of Hematology|August 17, 2013
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patientsThomas S Y Chan, Harinder Gill, Yu-Yan Hwang, et al.
Journal of Hematology & Oncology|September 5, 2015
Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 studyNeeraj Gupta, Yeow Tee Goh, Chang-Ki Min, et al.
Pageof 10